Enhancing Translational Mood Disorders Research at UTHSCSA
Enhancing Translational Mood Disorders Research at UTHSCSA
批准号:
7856286
负责人:
David A Morilak
金额:
$71.83万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31
关键词:
AccountingAddressAffectAgingAnxiety DisordersAppointmentAreaAwarenessBasic ScienceBiological MarkersBrainCaliberCardiovascular DiseasesClinicalClinical InvestigatorClinical ResearchCognitionCognitiveCoinCollaborationsComplementComplexCountryCytokine SignalingDataDevelopmentDiabetes MellitusDirect CostsDiseaseDisease ProgressionEarly treatmentEating DisordersEmotionsEndocrineEnvironmentEnvironmental Risk FactorEpigenetic ProcessEquipment and SuppliesEtiologyEventFacultyFosteringFunctional disorderFundingGeneticGenetic Predisposition to DiseaseGoalsGrantHealth SciencesHealth StatusImmune System DiseasesInstitutionInterventionKnowledgeLaboratory ResearchLifeLife StressMajor Depressive DisorderMedicalMental HealthMental disordersMentorsModelingMolecularMood DisordersMoodsMovementNational Institute of Mental HealthNeurobiologyNeuronal PlasticityNeurosciencesNeurotransmitter ReceptorObesityPathway interactionsPatientsPatternPeer GroupPersonsPharmacologyPhysiologicalPost-Traumatic Stress DisordersProcessPsychiatryPublicationsRecoveryRecruitment ActivityResearchResearch ActivityResearch PersonnelResearch SubjectsRestRiskRisk FactorsRoleScientistSensory ProcessSeveritiesStagingStrategic PlanningStressStructureSubstance abuse problemSymptomsSystemTexasToxic effectTrainingTranslational ResearchTreatment EfficacyUnited StatesUniversitiesWagesbasecardiovascular disorder preventioncareer developmentdepresseddepressionenvironmental stressorimprovedinterestmembermonoamineneurobiological mechanismneurochemistrynovelpre-clinicalprogramspublic health relevancerelating to nervous systemresilienceresponsetheoriestreatment response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal is submitted by the Mood Disorders Translational Core Center (MD-TCC), within the Center for Biomedical Neuroscience at the University of Texas Health Science Center at San Antonio. The MD-TCC is comprised of a core group of preclinical and clinical investigators from the Departments of Pharmacology and Psychiatry who share an interest in research into the mechanisms and treatment of depression and other mood disorders. This is an active and interactive group, with ample evidence of collaborative publication and funding. The proposal is for funding to support the recruitment of two high-caliber new faculty members into this group over two years, requesting $250,000 per year in direct costs for each to support their salary and benefits as well as salary and benefits for one new laboratory research personnel slot for each, equipment and supplies as appropriate to their new research programs. One of these new faculty will be a preclinical scientist with a primary appointment in the Department of Pharmacology, and the other will be a translational/clinical scientist with a primary appointment in the Department of Psychiatry. Both will have been trained in an environment of collaborative translational research. We plan to try to coordinate the recruitment of these two scientists such that their own research interests will not only complement and integrate them into the MD-TCC, but will also complement and Integrate with each other. Possible areas in which we plan to target our search could include genetics and epigenetics of depression; etiology and treatment of co-morbid cardiovascular disease and depression; neuroimmune function and brain cytokine signaling in depression; factors affecting vulnerability and resilience in development and aging. The senior members of the MD-TCC will not only provide the new faculty members with ample opportunities for productive collaboration, but will also provide mentoring, advice and guidance in many aspects of their career development, and will provide a peer group assisting them in the development and refinement of research programs that will be competitive for renewable external funding, most notably from NIMH. The translational research activities of the MD-TCC, and those of the new faculty that this center grant will support, are consistent with the goals of the NIMH strategic plan, and of the Recovery Act.
PUBLIC HEALTH RELEVANCE: Depression is a debilitating and costly disorder. Consistent with the goals of the NIMH Strategic Plan, the MD-TCC brings together preclinical and clinical researchers at the UTHSCSA, to foster the movement of basic science discoveries into clinical research, and ultimately to improving the treatment of depression. This proposal advances that purpose by supporting the recruitment of two new faculty into this group.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapy-induced cognitive impairment in a rat model of prostate cancer
-
批准号:10766874
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2023
-
负责人:David A Morilak
-
依托单位:
Cognitive impairment associated with androgen deprivation therapy for prostate cancer
-
批准号:10527354
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2018
-
负责人:David A Morilak
-
依托单位:
Cognitive impairment associated with androgen deprivation therapy for prostate cancer
-
批准号:10287767
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2018
-
负责人:David A Morilak
-
依托单位:
Cognitive impairment associated with androgen deprivation therapy for prostate cancer
-
批准号:10310426
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2018
-
负责人:David A Morilak
-
依托单位:
Cognitive impairment associated with androgen deprivation therapy for prostate cancer
-
批准号:10059183
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2018
-
负责人:David A Morilak
-
依托单位:
Treating PTSD and depression: Mechanisms of pharmacotherapy and psychotherapy in rats
-
批准号:10250669
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:David A Morilak
-
依托单位:
Treating PTSD and depression: Mechanisms of pharmacotherapy and psychotherapy in rats
-
批准号:10620164
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:David A Morilak
-
依托单位:
Treating PTSD and depression: Mechanisms of pharmacotherapy and psychotherapy in rats
-
批准号:10392391
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:David A Morilak
-
依托单位:
Integrated Graduate Training Program in Neuroscience, UTHSCSA
-
批准号:10625662
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2013
-
负责人:David A Morilak
-
依托单位:
Integrated Graduate Training Program in Neuroscience, UTHSCSA
-
批准号:10430193
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2013
-
负责人:David A Morilak
-
依托单位:
Integrated Graduate Training Program in Neuroscience, UTHSCSA
-
批准号:8675972
-
项目类别:
-
资助金额:$6.54万
-
财政年份:2013
-
负责人:David A Morilak
-
依托单位:
Integrated Graduate Training Program in Neuroscience, UTHSCSA
-
批准号:10200899
-
项目类别:
-
资助金额:$10.86万
-
财政年份:2013
-
负责人:David A Morilak
-
依托单位:
Integrated Graduate Training Program in Neuroscience, UTHSCSA
-
批准号:9301673
-
项目类别:
-
资助金额:$4.08万
-
财政年份:2013
-
负责人:David A Morilak
-
依托单位:
Integrated Graduate Training Program in Neuroscience, UTHSCSA
-
批准号:8473614
-
项目类别:
-
资助金额:$6.43万
-
财政年份:2013
-
负责人:David A Morilak
-
依托单位:
Selective negative allosteric modulators of alpha 5-GABAA receptors: novel psychotherapeutic drugs
-
批准号:10158002
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:David A Morilak
-
依托单位:
Selective negative allosteric modulators of alpha 5-GABAA receptors: novel psychotherapeutic drugs
-
批准号:10374014
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:David A Morilak
-
依托单位:
Enhancing Translational Mood Disorders Research at UTHSCSA
-
批准号:7937814
-
项目类别:
-
资助金额:$71.83万
-
财政年份:2009
-
负责人:David A Morilak
-
依托单位:
Cognitive Effects of 5-HT and SSRIs in Rat Prefrontal Cortex
-
批准号:7744009
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2008
-
负责人:David A Morilak
-
依托单位:
Cognitive Effects of 5-HT and SSRIs in Rat Prefrontal Cortex
-
批准号:7577265
-
项目类别:
-
资助金额:$7.41万
-
财政年份:2008
-
负责人:David A Morilak
-
依托单位:
Noradrenergic mechanisms in antidepressant drug effects
-
批准号:7394417
-
项目类别:
-
资助金额:$30.13万
-
财政年份:2006
-
负责人:David A Morilak
-
依托单位:
海外基金